Direkt zum Inhalt
Merck

A rare sugar xylitol. Part I: the biochemistry and biosynthesis of xylitol.

Applied microbiology and biotechnology (2007-01-12)
Tom Birger Granström, Ken Izumori, Matti Leisola
ZUSAMMENFASSUNG

The rare sugar xylitol is a five-carbon polyol (pentitol) that has beneficial health effects. Xylitol has global markets and, therefore, it represents an alternative to current dominant sweeteners. The research on microbial reduction of D-xylose to xylitol has been focused on metabolically engineered Saccharomycess cerevisiae and Candida strains. The Candida strains have an advantage over the metabolically engineered S. cerevisiae in terms of D-xylose uptake and maintenance of the intracellular redox balance. Due to the current industrial scale production of xylitol, it has become an inexpensive starting material for the production of other rare sugar. The first part of this mini-review concentrates on the biochemistry of xylitol biosynthesis and the problems related to intracellular redox balance.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Xylit, ≥99% (GC)
Sigma-Aldrich
Xylit
Supelco
Xylit, Pharmaceutical Secondary Standard; Certified Reference Material
Xylit, European Pharmacopoeia (EP) Reference Standard